Open AccessOverexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
Author(s) -
Jie Jiang,
Bin Liu,
Ruilin Liu,
Wenzhuo Yang
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s296069
Subject(s) - hepatocellular carcinoma , cancer research , biology , survival analysis , immunohistochemistry , carcinogenesis , oncology , methylation , medicine , cancer , immunology , dna , genetics
Taspase 1 (TASP1) is a highly conserved protease involved in site-specific proteolysis. Existing researches have revealed a link between TASP1 expression and carcinogenesis. However, limited data are available regarding the prognosis and functions of TASP1 in hepatocellular carcinoma (HCC).